Proteomic analysis of peripheral leukocytes in Alzheimer's disease patients treated with divalproex sodium
- 21 May 2007
- journal article
- clinical trial
- Published by Elsevier in Neurobiology of Aging
- Vol. 29 (11) , 1631-1643
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- Two-dimensional protein electrophoresis: From molecular pathway discovery to biomarker discovery in neurological disordersNeuroRX, 2006
- Epigenetic therapy of cancer: past, present and futureNature Reviews Drug Discovery, 2006
- Enhanced ROS-Generation in Lymphocytes from Alzheimer’s PatientsPharmacopsychiatry, 2005
- Oxidative imbalance and cathepsin D changes as peripheral blood biomarkers of Alzheimer disease: A pilot studyFEBS Letters, 2005
- Current two‐dimensional electrophoresis technology for proteomicsProteomics, 2004
- Alzheimer Patients Treated With an AchE Inhibitor Show Higher IL-4 and Lower IL-1β Levels and Expression in Peripheral Blood Mononuclear CellsJournal of Clinical Psychopharmacology, 2004
- Histone Deacetylase Is a Target of Valproic Acid-Mediated Cellular DifferentiationCancer Research, 2004
- Presenilin mutations and calcium signaling defects in the nervous and immune systemsBioEssays, 2001
- Enhanced Proliferation of Lymphoblasts from Patients with Alzheimer Dementia Associated with Calmodulin-Dependent Activation of the Na+/H+ ExchangerNeurobiology of Disease, 2001
- Lymphocytes and neutrophils as peripheral models to study the effect of β-amyloid on cellular calcium signalling in Alzheimer's diseaseLife Sciences, 1996